Last Update 03 May 26
ALTR: Fair Value View Will Rely On Margin And Discount Rate Assumptions
Analysts have nudged their price target on Altri SGPS slightly higher to €5.38. This reflects updated assumptions around discount rates, revenue growth, profit margins and future P/E expectations.
Valuation Changes
- Fair Value: unchanged at €5.38 per share, indicating the updated assumptions offset each other overall.
- Discount Rate: reduced slightly from 10.45% to 10.17%, which raises the present value of future cash flows.
- Revenue Growth: raised moderately from 6.58% to 7.48%, reflecting higher expectations for future € revenue expansion.
- Net Profit Margin: nudged up from 10.33% to 10.60%, pointing to slightly stronger expected earnings efficiency on € sales.
- Future P/E: trimmed from 17.16x to 16.56x, implying a marginally lower valuation multiple applied to projected earnings.
Key Takeaways
- Expansion into sustainable fibers and specialty bioproducts increases exposure to higher-margin markets, reduces reliance on commoditized pulp cycles, and supports long-term margin growth.
- Vertical integration, cost optimization, and secure sustainable feedstock improve revenue stability and margin resilience, positioning Altri for stronger growth amid evolving market dynamics.
- Trade uncertainties, pricing pressures, large investments, and regional operational risks threaten profitability, while diversification efforts carry significant execution and market adoption risks.
Catalysts
About Altri SGPS- Produces and sells cellulosic fibers in Portugal and internationally.
- Altri's strategic investment in AeoniQ and entry into sustainable, high-value cellulosic textile fibers-offering renewable, biodegradable, plastic-free alternatives to polyester and nylon-positions the company to capture expanding demand driven by tighter environmental regulations and global adoption of renewable materials, supporting higher revenues and elevated long-term EBITDA margins.
- The full migration of Biotek to dissolving pulp production by end-2026, alongside new acetic acid and furfural capacity, will increase exposure to higher-margin specialty pulp and bioproducts, reducing reliance on commoditized pulp cycles and enabling stronger net margin and earnings growth.
- Altri's newly established forestry platform in Northern Spain (via the Greenalia acquisition) strengthens vertical integration and enhances sustainable feedstock security, improving cost control and enabling the company to benefit from growing customer/premium market preference for traceable, certified wood-based products, positively impacting revenue stability and potential margin improvement.
- Ongoing and quantifiable cost optimization programs-including improved operational efficiencies, reductions in cash costs, and resource productivity gains from investments in Industrial 4.0-support enhanced EBITDA margins even in periods of market volatility, creating earnings leverage as pricing and demand normalizes.
- As global pulp markets stabilize from current tariff disruptions and macro headwinds, Altri is positioned to benefit from the long-term consumption growth of tissue/hygiene and specialty paper in emerging markets, creating a structural upward trend in sales volumes and price realization.
Altri SGPS Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming Altri SGPS's revenue will grow by 7.5% annually over the next 3 years.
- Analysts assume that profit margins will increase from 3.2% today to 10.6% in 3 years time.
- Analysts expect earnings to reach €89.0 million (and earnings per share of €0.44) by about May 2029, up from €21.4 million today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting €152.0 million in earnings, and the most bearish expecting €44.1 million.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 16.6x on those 2029 earnings, down from 47.9x today. This future PE is lower than the current PE for the GB Forestry industry at 27.3x.
- Analysts expect the number of shares outstanding to remain consistent over the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 10.17%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- Persistent global trade uncertainties, including newly implemented U.S. tariffs, have directly contributed to pulp demand slowdowns, particularly in Asia, and any prolonged or escalating trade tensions may further depress Altri's international sales, thus negatively impacting revenue growth and long-term earnings visibility.
- Weakness in global and regional pulp pricing is evident, with average prices in Europe down 13% in USD and dissolving pulp prices dropping 10% year-on-year, which, coupled with intermittent negative volume trends, places sustained pressure on Altri's net margins and overall profitability.
- The planned diversification into textile fibers through AeoniQ, while potentially high margin, introduces execution and scalability risk; given early stage commercial production and uncertain speed of brand adoption in a highly competitive and innovating market, this could delay or diminish the expected earnings uplift for several years.
- High capital expenditure requirements in 2025 and 2026-for both the Biotek conversion and AeoniQ investments-are driving up net debt (already at 2.1x EBITDA), making Altri more vulnerable to interest rate risks and to potential cash flow or balance sheet strain if end-market recovery is weaker or slower than anticipated.
- Geographic concentration of operations in Portugal and select European markets, combined with elevated working capital driven by seasonal wood stocking, exposes Altri to regional risks (such as drought, forest fires, and regulatory shifts) that could disrupt continuity of operations, heighten costs, and adversely affect long-term revenue and return on capital employed.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of €5.38 for Altri SGPS based on their expectations of its future earnings growth, profit margins and other risk factors.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be €839.7 million, earnings will come to €89.0 million, and it would be trading on a PE ratio of 16.6x, assuming you use a discount rate of 10.2%.
- Given the current share price of €4.99, the analyst price target of €5.38 is 7.2% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Altri SGPS?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.